|
Market Closed -
NYSE
21:04:03 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 108.33 USD | -0.42% |
|
-2.92% | -13.54% |
| 09-04 | US companies face rise in cyber attacks | RE |
| 09-01 | Mead Johnson wins US federal bellwether trial over preterm infant formula Enfamil | RE |
| Market Cap | 188B 162B 152B 139B 260B 17,786B 261B 1,801B 699B 9,117B 707B 691B 29,408B | P/E 2026 * |
31.2x | P/E 2027 * | 24x |
|---|---|---|---|---|---|
| Enterprise Value | 212B 183B 172B 157B 294B 20,047B 295B 2,030B 788B 10,276B 797B 779B 33,148B | EV / Sales 2026 * |
4.22x | EV / Sales 2027 * | 3.83x |
| Free-Float |
86.16% | Yield 2026 * |
2.36% | Yield 2027 * | 2.52% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
Tradegate
| ABL | Real-time | |
|
Boerse Muenchen
| ABL | Real-time | |
|
Xetra
| ABL | Delayed | |
|
CBOE
| Real-time | ||
|
London S.E.
| ABT | Delayed | |
|
Borsa Italiana
| 1ABT | End-of-day quote | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Lima
| ABTUS | End-of-day quote | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
CBOE
| ABT | Real-time | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Santiago S.E.
| ABT | End-of-day quote |
Last Transcript : Abbott Laboratories
| 1 day | -0.42% | ||
| 1 week | -2.92% | ||
| Current month | -1.84% | ||
| 1 month | +1.13% | ||
| 3 months | +24.53% | ||
| 6 months | -4.65% | ||
| Current year | -13.54% |
| 1 week | 107.36 |  | 113.91 |
| 1 month | 104.2 | | 117.34 |
| Current year | 81.97 | | 129.46 |
| 1 year | 81.97 | | 137.49 |
| 3 years | 81.97 | | 141.23 |
| 5 years | 81.97 | | 142.6 |
| 10 years | 37.38 | | 142.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 30/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 31/08/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 08/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 08/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 15/02/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/08/26 | Exercice | Chief Executive Officer | 1,196,496 | 0.0691% | ||
| 12/08/26 | Other | EXECUTIVE VICE PRESIDENT | -12 | 0.0000% | - | |
| 30/06/26 | Free | Director | 416 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.42% | -2.92% | -18.04% | +5.33% | 188B | |
| +1.15% | +4.67% | +2.08% | +14.66% | 119B | |
| -1.86% | +3.03% | +12.13% | +89.16% | 64.35B | |
| -1.31% | -1.33% | +23.64% | +48.69% | 52.59B | |
| -1.54% | -1.80% | -2.57% | -33.66% | 51.11B | |
| -2.02% | -1.56% | +11.38% | -13.73% | 33.85B | |
| 0.00% | +5.60% | - | - | 32.1B | |
| -0.81% | -1.77% | +36.56% | -16.61% | 24.12B | |
| -1.44% | -5.00% | -7.60% | +9.97% | 23.39B | |
| -0.69% | -3.60% | -7.37% | -2.72% | 22.12B | |
| Average | -0.89% | -0.18% | +5.58% | +11.23% | 61.1B | |
| Weighted average by Cap. | -0.57% | -0.65% | -0.57% | +14.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.3B 43.32B 40.69B 37.2B 69.6B 4,753B 69.84B 481B 187B 2,436B 189B 185B 7,858B | 54.65B 47.06B 44.21B 40.42B 75.61B 5,163B 75.88B 523B 203B 2,646B 205B 201B 8,537B |
| Net income | 6.23B 5.37B 5.04B 4.61B 8.62B 589B 8.65B 59.62B 23.15B 302B 23.4B 22.89B 974B | 7.92B 6.82B 6.41B 5.86B 10.97B 749B 11B 75.8B 29.43B 384B 29.75B 29.11B 1,238B |
| Net Debt | 23.94B 20.62B 19.37B 17.71B 33.12B 2,262B 33.24B 229B 88.91B 1,159B 89.88B 87.93B 3,740B | 20.96B 18.05B 16.95B 15.5B 29B 1,980B 29.1B 200B 77.84B 1,015B 78.68B 76.97B 3,274B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | US$108.33 | -0.42% | 6,875,099 |
| 03/09/26 | US$108.79 | -1.52% | 5,297,911 |
| 02/09/26 | US$110.47 | +1.41% | 8,458,886 |
| 01/09/26 | US$108.93 | -1.30% | 7,229,416 |
| 31/08/26 | US$110.36 | -1.88% | 10,691,544 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
